Australia markets open in 4 hours 53 minutes

Sorrento Therapeutics, Inc. (SRNE)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0200+0.0055 (+39.86%)
As of 02:45PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-493,568
-572,843
-428,325
-298,461
Depreciation & amortisation
12,751
13,245
12,462
11,007
Deferred income taxes
-34,775
-1,836
-35,927
-2,125
Stock-based compensation
80,296
74,847
90,188
31,419
Change in working capital
34,579
69,551
-2,791
3,799
Accounts receivable
-7,662
-5,680
-2,957
-1,051
Inventory
34
-9,510
-6,276
1,532
Accounts payable
5,381
9,870
-3,878
-3,677
Other working capital
-308,998
-307,514
-290,692
-166,064
Other non-cash items
-28,129
-64,117
61,251
59,591
Net cash provided by operating activities
-297,656
-293,857
-281,821
-159,536
Cash flows from investing activities
Investments in property, plant and equipment
-11,342
-13,657
-8,871
-6,528
Acquisitions, net
-15,001
-14,861
-36,049
-33,395
Sales/maturities of investments
654
0
124,767
0
Net cash used for investing activities
-25,689
-28,518
79,847
-39,923
Cash flows from financing activities
Debt repayment
-165,728
-188,311
-85,656
-205,564
Common stock issued
406,983
402,334
201,825
317,865
Common stock repurchased
-
0
0
-55,000
Other financing activities
-
426
-
-
Net cash used provided by (used for) financing activities
357,495
311,718
181,332
174,239
Net change in cash
34,150
-10,657
-20,642
-25,220
Cash at beginning of period
39,735
36,665
56,464
80,769
Cash at end of period
73,885
23,634
36,665
56,464
Free cash flow
Operating cash flow
-297,656
-293,857
-281,821
-159,536
Capital expenditure
-11,342
-13,657
-8,871
-6,528
Free cash flow
-308,998
-307,514
-290,692
-166,064